Literature DB >> 19112799

Modified Welsh regimen: a promising therapy for actinomycetoma.

D K Damle1, P M Mahajan, S N Pradhan, V A Belgaumkar, A P Gosavi, S N Tolat, N R Gokhale, C B Mhaske.   

Abstract

BACKGROUND: Mycetoma has a worldwide geographical distribution which is extremely uneven; however, it is a common disease in India and responsible for causing significant morbidity. Treatment of this condition is often a challenge for the treating dermatologist. The authors report a promising therapy for patients of actinomycotic mycetoma.
METHODS: This assessment series included 18 patients with a confirmed diagnosis of actinomycetoma, and who had shown a poor response to previous treatments. Patient received a combination therapy of the Welsh regimen (amikacin along with cotrimoxazole) to which rifampicin was added as a third drug. Clinical evaluation included radiology and laboratory investigations.
RESULTS: Sixteen patients out of 18 completed the combination therapy, which lead to remission. Two patients were lost to follow-up. Of the 16 patients in remission, no recurrence was observed during a follow-up period of up to 18 months.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112799

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

Review 1.  Mycetoma: An Update.

Authors:  Vineet Relhan; Khushbu Mahajan; Pooja Agarwal; Vijay Kumar Garg
Journal:  Indian J Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.494

2.  Mycetoma: A Common Yet Unrecognized Health Burden in Central India.

Authors:  Gitesh U Sawatkar; Vaishali H Wankhade; Bhagyashree B Supekar; Rajesh Pratap Singh; Dharitri M Bhat; Supriya S Tankhiwale
Journal:  Indian Dermatol Online J       Date:  2019 May-Jun

3.  Mycetoma foot.

Authors:  Somnath Gooptu; Iqbal Ali; Gurjit Singh; R N Mishra
Journal:  J Family Community Med       Date:  2013-05

4.  A 48-year-old male immigrant with a painful foot mass.

Authors:  Mansoor Mehmood; Ruba A Halloush; Faisal A Khasawneh
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-07       Impact factor: 2.471

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.